Atlas Bio
Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.
$2.5MPreviously undisclosed pre-seed
LeadActivity from announced rounds
Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.
Builds an open-source AI-first control plane for engineers and agents to manage production infrastructure